Objective Capital Objective Capital is an independent provider of corporate investment research. Our clients are companies, or their advisors, that are either private, publicly listed, or in the process of preparing for listing. Objective’s life sciences research, produced regularly, and disseminated widely is an essential investment and communications tool. Sponsoring research is the most effective way for a company to build the strategic relationship it needs with the market to access investment funds, potential partners and ensure market interest in its stock. It also sends a strong message to potential investors that the company is committed to an open and transparent relationship with the market and ensuring that there will be a regular flow of investment research available. Readers of our research include individuals, professional investors, fund managers, family offices and corporations, who have a private or professional interest in being informed about life science opportunities. For more information please contact: |
 |
Pharmalicensing Pharmalicensing is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting in- and out-licensing activities, Pharmalicensing provides partnering services, business development reports, industry news and a jobs source for candidates and employers. Pharmalicensing is used by over 90,000 users per month and is a division of UTEK Corporation. Visit www.pharmalicensing.com |
 |